Search results
25 sty 2023 · Bivalent boosters provided substantial additional protection against severe omicron infection in persons who had previously been vaccinated or boosted, although the effectiveness waned over...
- Correspondence May 4, 2023 Bivalent Boosters Against Severe Omicron Infection
To the Editor: Lin and colleagues (Feb. 23 issue)1 report...
- Images in Clinical Medicine Pseudothrombocytosis K. Liapis and S. Papadakis
An 80-year-old woman who had been admitted with severe burns...
- Perspective The Princess and The He B.M. Reilly
A retired physician volunteers to help teach bedside skills...
- Editorial Hemophilia a Gene Therapy — Some Answers, More Questions L.A. George
Hemophilia A is an X-linked disorder caused by the loss of...
- Perspective Fraud, Abuse, and Financial Conflicts of Interest Z. Buck
Increased attention and ever-growing complexity in the area...
- Perspective Protecting The Legitimacy of Medical Expertise R.J. Baron and C.H. Coleman
Amid the Covid-19 pandemic, state lawmakers have embraced...
- ITT Episode 3
In this episode of “Intention to Treat,” a study participant...
- Review Article Acute Kidney Injury in Patients With Cirrhosis M.K. Nadim and G. Garcia-Tsao
The authors review the pathophysiology, revised diagnostic...
- Correspondence May 4, 2023 Bivalent Boosters Against Severe Omicron Infection
8 kwi 2022 · The COV-BOOST randomised controlled trial found that booster schedules increased both humoral and cellular responses to SARS-CoV-2, and that the side-effects were similar to those seen with primary vaccination.
13 kwi 2023 · Our findings suggest that, in adults aged 65 years or older, the vaccine effectiveness of the bivalent mRNA vaccine booester dose is 72% (95% CI 60–81) for COVID-19 related hospitalisation and 68% (42–82) for COVID-19-related death. Implications of all the available evidence.
14 sty 2022 · We used a test-negative case–control design to estimate the relative effectiveness of a booster dose of BNT162b2 (Pfizer-BioNTech) compared to only a two-dose primary course (at least 175...
5 wrz 2024 · The updated mRNA vaccine doses — one from Pfizer and the other from Moderna — will target just one strain: KP.2, the FDA release explains.
23 mar 2022 · Active immunization with the BNT162b2 vaccine (Pfizer–BioNTech) has been a critical mitigation tool against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the ...
31 sie 2022 · The potential role of an omicron-containing booster is currently being explored, but a study in nonhuman primates showed that an omicron-specific mRNA vaccine was not better than the original...
